Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
21.18
-0.51 (-2.35%)
Sep 21, 2026, 11:01 AM EDT - Market open
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $582.77 million as of September 21, 2026. Its market cap has decreased by -14.70% in one year.
Market Cap
582.77M
Enterprise Value
41.03M
1-Year Change
-14.70%
Ranking
Category
Stock Price
$21.18
ChartMarket Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $582.77M, an increase of 272.38%. That is a compound annual growth rate of 14.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 582.77M | -28.24% |
| Dec 31, 2025 | 812.10M | 43.76% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
| Sep 29, 2016 | 156.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CareDx | 2.78B |
| NeoGenomics | 2.56B |
| Freenome | 1.84B |
| Personalis | 1.75B |
| OPKO Health | 1.25B |
| Castle Biosciences | 1.08B |
| Myriad Genetics | 372.08M |
| Biodesix | 308.09M |